2:30 pm14:30

Progyny, Inc. Announces Global Partnership with Merck KGaA, Darmstadt, Germany

Effective today, Merck KGaA, Darmstadt, Germany, will have non-exclusive global marketing and commercialization rights to Progyny's Early Embryo Viability Assessment Test, or Eeva® Test, while the former agreement had granted Merck KGaA, Darmstadt, Germany exclusive rights to commercialize the Eeva® Test in Europe and Canada, with the option to extend to selected countries.

2:30 pm14:30

Mercer Forms Strategic Alliance with Progyny to Offer Innovative Fertility Benefits

Mercer announced today it has formed a strategic alliance with Progyny to provide employers and their employees with the innovative SMART™ (Science and Member-Driven Assisted Reproductive Technology) fertility benefit product which will enable companies to significantly reduce newborn intensive care unit (NICU) and associated high-risk maternity-related costs, while increasing access and positive outcomes.